Skip to main navigation Skip to search Skip to main content

Confirmation of a new phenotype in an individual with a variant in the last part of exon 30 of CREBBP

  • Andrea Angius
  • , Paolo Uva
  • , Manuela Oppo
  • , Ivana Persico
  • , Stefano Onano
  • , Stefania Olla
  • , Valentina Pes
  • , Chiara Perria
  • , Gianmauro Cuccuru
  • , Rossano Atzeni
  • , Gigliola Serra
  • , Francesco Cucca
  • , Stefano Sotgiu
  • , Raoul C. Hennekam
  • , Laura Crisponi
  • Istituto di Ricerca Genetica e Biomedica, Monserrato (CA), Italy
  • Centre for Advanced Studies, Pula (CA), Italy
  • Dipartimento di Scienze Biomediche, Sassari, Italy
  • Clinica di Neuropsichiatria Infantile, Sassari, Italy
  • Department of Pediatrics, Amsterdam, Netherlands

Research output: Contribution to journalArticleAcademicpeer-review

34 Downloads (Pure)

Abstract

We report here a novel de novo missense variant affecting the last amino acid of exon 30 of CREBBP [NM_004380, c.5170G>A; p.(Glu1724Lys)] in a 17-year-old boy presenting mild intellectual disability and dysmorphisms but not resembling the phenotype of classical Rubinstein–Taybi syndrome. The patient showed a marked overweight from early infancy on and had cortical heterotopias. Recently, 22 individuals have been reported with missense mutations in the last part of exon 30 and the beginning of exon 31 of CREBBP, showing this new phenotype. This additional case further delineates the genotype–phenotype correlations within the molecular and phenotypic spectrum of variants in CREBBP and EP300.
Original languageEnglish
Pages (from-to)634-638
JournalAmerican journal of medical genetics. Part A
Volume179
Issue number4
DOIs
Publication statusPublished - 1 Apr 2019

Fingerprint

Dive into the research topics of 'Confirmation of a new phenotype in an individual with a variant in the last part of exon 30 of CREBBP'. Together they form a unique fingerprint.

Cite this